Detection and characterization of carbapenemase-producing Enterobacteriaceae in cancer patients: first Sri Lankan report of blaVIM in Enterobacteriaceae

被引：0
作者：
Chathuranga, Gayashan [1 ]
Dissanayake, Thushari [2 ]
Fernando, Neluka [2 ]
Wanigatunge, Chandanie Amila [3 ]
机构：
[1] Univ Sri Jayewardenepura, Fac Allied Hlth Sci, Dept Med Lab Sci, Nugegoda, Sri Lanka
[2] Univ Sri Jayewardenepura, Fac Med Sci, Dept Microbiol, Nugegoda, Sri Lanka
[3] Univ Sri Jayewardenepura, Fac Med Sci, Dept Pharmacol, Nugegoda, Sri Lanka
来源：
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2024年 / 18卷 / 11期
关键词：
Carbapenem-resistant Enterobacteriaceae (CRE); cancer patient; carbapenemase-encoding gene; GRAM-NEGATIVE BACTERIA; METALLO-BETA-LACTAMASE; RESISTANT ENTEROBACTERIACEAE; KLEBSIELLA-PNEUMONIAE; EPIDEMIOLOGY; INFECTION; MECHANISMS; OUTBREAK; OUTCOMES; THREAT;
D O I：
10.3855/jidc.19499
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are an important cause of infections in cancer patients. The proportion of carbapenem resistance and the types of carbapenemase-encoding genes in Enterobacteriaceae isolated from cancer patients were determined in this study. Methodology: Bacteria isolated from adult, in-ward cancer patients with lower respiratory tract infections (LRTI), skin and soft tissue infections (SSTI), or urinary tract infections (UTI) were included in the study. Enterobacteriaceae were identified up to the species level by API (R) 20E test kits. Carbapenem resistance was defined as non-susceptibility to either imipenem or meropenem in the disc diffusion test. Major carbapenemase-encoding genes (blaKPC, blaNDM, blaOXA-48, blaIMP, and blaVIM) were detected by the GeneXpert (R) Carba-R real-time PCR instrument. Results: Enterobacteriaceae comprised 57% (94/165) of the bacterial isolates. Carbapenem resistance among Enterobacteriaceae was 46.8% (44/94). Klebsiella pneumoniae (65.9%, 29/44) was the predominant CRE isolate followed by Escherichia coli (25%, 11/44). The majority of CRE isolates (72.7%, 32/44) had a meropenem MIC of >= 32 mu g/mL. Carbapenemase-encoding genes were identified in 43 of the 44 CRE isolates. blaNDM was the most prevalent carbapenemase-encoding gene and was detected in 67.4% (29/43) of Enterobacteriaceae isolates. No isolate was positive for blaIMP. Sixteen (37.2%) isolates co-harbored more than one carbapenemase-encoding gene. Two Enterobacteriaceae isolates were found to harbor blaVIM. Conclusions: Nearly all CRE isolated in this study were carbapenemase producers. This study documented the emergence of blaVIM harboring Enterobacteriaceae for the first time in Sri Lanka.
引用
收藏
页码：1715 / 1720
页数：6
相关论文
共 31 条
  • [1] Effectiveness of cancer treatments threatened by rising antibiotic resistance, (2020)
  • [2] Nesher L, Rolston KV, The current spectrum of infection in cancer patients with chemotherapy related neutropenia, Infection, 42, pp. 5-13, (2014)
  • [3] Jaiswal SR, Gupta S, Kumar RS, Sherawat A, Rajoreya A, Dash SK, Bhagwati G, Chakrabarti S, Gut colonization with carbapenem-resistant Enterobacteriaceae adversely impacts the outcome in patients with hematological malignancies: Results of a prospective surveillance study, Mediterr J Hematol Infect Dis, 10, (2018)
  • [4] Lu L, Xu C, Tang Y, Wang L, Cheng Q, Chen X, Zhang J, Li Y, Xiao H, Li X, The threat of carbapenem-resistant gram-negative bacteria in patients with hematological malignancies: Unignorable respiratory non-fermentative bacteria-derived bloodstream infections, Infect Drug Resist, 15, pp. 2901-2914, (2022)
  • [5] Nordmann P, Dortet L, Poirel L, Carbapenem resistance in Enterobacteriaceae: here is the storm!, Trends Mol Med, 18, pp. 263-272, (2012)
  • [6] Nordmann P, Poirel L, Epidemiology and diagnostics of carbapenem resistance in Gram-negative bacteria, Clin Infect Dis, 69, pp. S521-S528, (2019)
  • [7] Meletis G, Carbapenem resistance: overview of the problem and future perspectives, Ther Adv Infect Dis, 3, pp. 15-21, (2016)
  • [8] Goodman KE, Simner PJ, Tamma PD, Milstone AM, Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE), Expert Rev Anti Infect Ther, 14, pp. 95-108, (2016)
  • [9] Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, Simner PJ, Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia, Clin Infect Dis, 64, pp. 257-264, (2017)
  • [10] Zhang Z, Wang D, Li Y, Liu Y, Qin X, Comparison of the performance of phenotypic methods for the detection of carbapenem-resistant Enterobacteriaceae (CRE) in clinical practice, Front Cell Infect Microbiol, 12, (2022)
1234